Does BELIMUMAB Cause Disease recurrence? 63 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Disease recurrence have been filed in association with BELIMUMAB (BENLYSTA). This represents 0.2% of all adverse event reports for BELIMUMAB.
63
Reports of Disease recurrence with BELIMUMAB
0.2%
of all BELIMUMAB reports
4
Deaths
22
Hospitalizations
How Dangerous Is Disease recurrence From BELIMUMAB?
Of the 63 reports, 4 (6.3%) resulted in death, 22 (34.9%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which BELIMUMAB Alternatives Have Lower Disease recurrence Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID